Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTLA-4 upregulation during aging.

Qibin Leng1, Zvi Bentwich, Gadi Borkow

  • 1Ruth Ben-Ari Institute of Clinical Immunology and AIDS Center, Kaplan Medical Center, Hebrew University Hadassah Medical School, 76100, Rehovot, Israel.

Mechanisms of Ageing and Development
|September 26, 2002
PubMed
Summary

As people age, their immune systems become less responsive. This study found that levels of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), a T-cell regulator, increase with age, contributing to immune senescence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Site-specific neoepitope induction by RNA editing reprograms tumor immunogenicity.

Frontiers in immunology·2026
Same author

Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection.

Nature microbiology·2026
Same author

In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8<sup>+</sup> T cell responses.

Journal for immunotherapy of cancer·2025
Same author

LTO1 and YAE1 regulate MHC-I expression via nonsense-mediated RNA decay in tumor cells.

Journal for immunotherapy of cancer·2025
Same author

Noninferiority of Copper Dressings Than Negative Pressure Wound Therapy in Healing Diabetic Wounds: A Randomized Clinical Trial.

Advances in wound care·2025
Same author

Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.

BMC cancer·2025

Area of Science:

  • Immunology
  • Gerontology
  • Cellular Biology

Background:

  • Immune system function declines with age, a process known as immune senescence.
  • Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is a key negative regulator of T-cell activity.
  • Understanding age-related changes in immune regulation is crucial for addressing health issues in older adults.

Purpose of the Study:

  • To investigate the relationship between aging and intracellular levels of CTLA-4 in healthy individuals.
  • To explore the correlation between CTLA-4 expression and markers of immune activation.
  • To elucidate the role of CTLA-4 in age-associated immune dysfunction.

Main Methods:

  • Measured intracellular CTLA-4 levels in CD4+ T-cells from 53 healthy individuals across a wide age range (18-94 years).

Related Experiment Videos

  • Utilized flow cytometry to quantify CTLA-4 expression (percentage and mean fluorescence intensity).
  • Assessed immune activation by measuring HLA-DR+CD3+ cell levels.

    • Main Results:

    • A significant positive correlation was observed between age and the percentage of CTLA-4+CD4+ cells (r=0.6, P<0.001).
    • Age was also significantly correlated with the mean fluorescence intensity of CTLA-4 (r=0.61, P<0.001), indicating increased molecular levels.
    • CTLA-4 levels showed a significant correlation with immune activation markers (HLA-DR+CD3+ cells, r=0.55, P<0.001).

    Conclusions:

    • Age-related immune senescence may be partly driven by chronic immune activation.
    • Increased CTLA-4, an inhibitory molecule, contributes to diminished T-cell function in aging.
    • Decreased CD28 costimulatory molecules alongside increased CTLA-4 may underlie age-associated immune anergy.